Survac APS
Records under this name other than the patents Survac APS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 5 of 5 · Back to Survac APS
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE48,522 | Survivin-derived peptides and uses thereof Term ended Term ended Jul 18, 2025 · From the USPTO record | Term ended | Term ended Jul 18, 2025 | From the USPTO record |
| US 7,892,559 | Survivin-derived peptides and use thereof Term ended Term ended Jun 13, 2025 · From the USPTO record | Term ended | Term ended Jun 13, 2025 | From the USPTO record |
| US 8,318,174 | Survivin-derived peptides and use thereof Term ended Term ended Apr 9, 2025 · From the USPTO record | Term ended | Term ended Apr 9, 2025 | From the USPTO record |
| US 7,687,465 | Therapeutic cancer vaccine Formerly held Term ended Term ended Apr 7, 2024 · From the USPTO record | Term ended | Term ended Apr 7, 2024 | From the USPTO record |
| US 9,534,030 | Survivin-derived peptides and uses thereof Surrendered on reissue Surrendered on reissue Apr 20, 2021 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Apr 20, 2021 | From the USPTO record |